RLRL showed the largest estimated effects and ranked highest among the evaluated interventions for one-year control of pediatric high myopia, while PSR, RGP, and orthokeratology also showed potential benefits.
Although current evidence suggests that RLRL is generally well tolerated in the short term, the retinal structural effects of long-term cumulative exposure and the boundaries of dose-related safety remain debated.
Immunofluorescence showed a progressive decline in nestin signal in the inner nuclear layer, which correlated with a composite behavioral deficit score across animals.
Shortened tear film break-up time (TBUT) independently causes refractive prediction error. Each 1-s TBUT increase raises the odds of target refraction nearly fivefold, with a ≥ 6-s clinical threshold.
Light-based therapies, particularly LLRL and short-wavelength light interventions, show promise as non-pharmacological approaches for myopia control; conversely, current evidence remains insufficient to establish their long-term safety.
The therapeutic effects of PBM appear to be dose-dependent and influenced by treatment parameters including wavelength, fluence, irradiance, and exposure protocol.
Available randomized evidence suggests that some interventions may reduce early refractive change in children classified as premyopic, while effects on axial elongation remain less certain.
Review · October 27, 2026 · Martinez-Perez C et al.
To address these limitations, we propose a precision-oriented framework that links clinical target, tissue-optical context, wavelength selection, patient- and site-specific modifiers, dosimetric implications, measurable endpoints, and evidence maturity.
This pilot study revealed that dual-wavelength LED phototherapy is safe and significantly reduces pain and discomfort in CEO, whereas topical antibiotics remain superior for otorrhea resolution.
These findings demonstrate consistent choroidal thickening following RLRL therapy in children with myopia and premyopia and support further investigation into the potential role of choroidal changes in myopia control.
LLLT appears to be well tolerated and may improve signs and symptoms of DED, particularly ocular discomfort. It may represent a promising standalone treatment option for patients in whom combination regimens involving IPL treatment are contraindicated.
All chromatic filters improved visual function, with benefits generally maintained after cessation. Yellow demonstrated an advantage over Orange for BCVA.
Pediatric ocular surface disease may present with severe objective findings despite minimal subjective symptoms, potentially delaying diagnosis and treatment.
BSM therapy can effectively relieve clinical symptoms and restore tear film homeostasis in patients with MGD, serving as a promising and viable therapeutic approach for MGD management.